Open AccessTargeted Treatment of Chronic Lymphocytic Leukemia: Clinical Utility of Acalabrutinib
Author(s) -
Candida Vitale,
Jamie Lynn Gibbons,
Alessandra Ferrajoli
Publication year - 2021
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s303060
Subject(s) - ibrutinib , bruton's tyrosine kinase , chronic lymphocytic leukemia , tolerability , medicine , clinical trial , drug , pharmacology , tyrosine kinase , oncology , leukemia , adverse effect , receptor